NCT03389490View on ClinicalTrials.gov

Toujeo Versus NPH Self-titration Study

PHASE4CompletedINTERVENTIONAL

Enrollment

50

Participants

Timeline

Start Date

January 1, 2018

Primary Completion Date

December 17, 2019

Study Completion Date

May 1, 2020

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG

Insulin Glargine 300 UNT/ML

Self titration of insulin glargine U300

DRUG

Neutral protamine hagedorn insulin

Self titration of NPH insulin

Trial Locations (1)

Unknown

Prince of Wales Hospital, Hong Kong

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Sanofi

INDUSTRY

lead

Elaine Chow

OTHER